Skip to main content

 

Earnings Potpourri

By Commentary No Comments

Four times a year public companies regale us with their (usually optimistic) views of the firm’s past performance, future prospects and market environment. Interesting information can occasionally be found by reviewing analyst call transcripts. Some current releases are discussed.

Read More

Shifts in Drug Marketing Spending

By Commentary No Comments

Pharmaceutical manufacturers have spent massive amounts of money on sending sales reps to visit individual physicians and on direct-to-consumer advertising, to the point that this spending is often larger than research and development costs. This spending may be shifting in some companies to more internet-based marketing.

Read More